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Introduction
Regulatory T cells (Treg) are crucial for maintaining
immune homeostasis and mediating immune tolerance.
Besides their immune regulatory function, Treg can pro-
duce pro-inflammatory cytokines such as interleukin
(IL)-17 and interferon (IFN)-g. Recently, our group has
identified CD161 as a marker for pro-inflammatory
FoxP3+ T cells which have classic Treg characteristics
but also have effector T cell functions (Pesenacker et al.,
2013). These data also demonstrated enhanced levels of
CD161 expressing Treg within the inflamed synovial
joints of Juvenile Idiopathic Arthritis (JIA) patients sug-
gesting a role for CD161+ Treg in disease. Therefore,
further characterization of this specific subset of Treg is
required to unravel its function in health and disease.
Objectives
The aim of this study was to define the phenotype of
the recently identified CD161 expressing Treg population
in healthy controls and JIA patients.
Methods
CD161+ Treg within peripheral blood mononuclear cells
(PBMC) of healthy controls (HC) (HC PBMC) and syno-
vial fluid mononuclear cells (SFMC) of JIA patients (JIA
SFMC) were analyzed by flow cytometry for the expres-
sion of Helios, programmed death (PD) 1, chemokine
(CXC motif) receptor 3 (CXCR3), cytotoxic T lympho-
cyte-associated protein 4 (CTLA4), glucocorticoid-induced
tumor necrosis factor receptor (GITR) and glycoprotein A
repetitions predominant (GARP).
Results
Clear phenotypic differences were observed between
CD161+ and CD161- Treg. CD161+ Treg expressed
lower levels of Helios compared to CD161- Treg in HC
PBMC and JIA SFMC. In addition, CD161+ Treg
showed an increased expression of PD1 compared to
CD161- Treg within HC PBMC. Expression of PD1 was
high on both CD161+ and CD161- Treg in JIA SFMC
compared to HC PMBC. Furthermore, CD161+ Treg
from HC PMBC expressed a slightly higher level of
CXCR3 compared to their CD161- counterparts. Among
JIA SFMC, the expression of CXCR3 was increased
compared to the levels within HC PMBC. The percen-
tage of CD161+ Treg expressing CTLA4 on the cell sur-
face was increased compared to CD161- Treg in HC
PBMC and JIA SFMC. Total CTLA4 expression was
enhanced on both CD161+ and CD161- Treg in JIA
SFMC. Expression of GITR by CD161+ Treg was
increased compared to CD161- Treg among HC PBMC
and JIA SFMC. Also, CD161+ Treg expressed higher
levels of GARP compared to CD161- Treg among
HC PBMC.
Conclusion
The selected markers are all involved in mechanisms by
which Treg exert their immune regulatory function.
Therefore, the observed phenotypic differences between
CD161+ and CD161- Treg may indicate differences in
functional mechanisms used by these two different Treg
populations in health and disease. Divergent functional
capacity between CD161+ and CD161- Treg could explain
the dual function of CD161 Treg in health and disease.
These data might contribute towards development of new
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